Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALC-919 for Common Warts
NCT02483455Phase 2Completed
- Sponsor
- Veloce BioPharma
- Start
- Apr 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ALC-919 in common warts, sponsored by Veloce BioPharma. Started Apr 2015; status: completed.
02
Drugs
ALC-919
03
Conditions
common warts
Beyond the preview
Go deeper on NCT02483455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02483455.